PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Medical Immunology (IMI), Université Libre de Bruxelles, Gosselies, Belgium; Department of Urology, CHU de Charleroi, Université Libre de Bruxelles, Charleroi, Belgium. Electronic address: Maxime.Rossi@ulb.be.\', \'Department of Intensive Care, CHU de Charleroi, Université Libre de Bruxelles, Charleroi, Belgium; Laboratory of Experimental Medicine (ULB 222 Unit), CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium.\', \'Laboratory of Experimental Medicine (ULB 222 Unit), CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0306-9877(20)31600-510.1016/j.mehy.2020.110242
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 33254548
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33254548>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33254548>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all